Parataxis Holdings, a subsidiary of the investment company focused on digital assets Parataxis Capital Management, is expected to launch a Bitcoin native treasury platform on the South Korean public market.
The firm announced on June 20 that it had concluded a final agreement to invest 29 billion South Korean Won (18.5 million dollars) in Bridge Biotherapeutics, a listed biotechnology company.
Following the acquisition, parataxy will have a majority interest in the company, which will be renamed Korea Parataxy and reused as the Treasury vehicle for the institutional exhibition in Bitcoin (BTC).
“Inspired by the growing interest in BTC treasury strategies observed in companies such as strategy in the United States and Metaplanet in Japan, we believe that institutional interest in this space increases worldwide,” said Andrew Kim, associated with Parataxis Capital. “We consider South Korea as an important market in the evolution of the adoption of the BTC.”
Kim added that the company’s intention is to support institutional access to Bitcoin while emphasizing good corporate governance and disciplined capital management.
Currently, the funds negotiated in exchange for Bitcoin (ETF) and investments in institutional cryptography are prohibited in South Korea.
However, the country’s financial services committee (SFC) has enabled 3,500 companies and professional investors to open “real names” accounts in the first half of 2025 as part of a pilot program aimed at gradually allowing institutional investments in digital assets.
In relation: “ Apple should buy bitcoin ” says Saylor, while the acquisition of action disappoints
The new parataxis platform was announced more than a week after the company whose headquarters is in New York announced its intention to make public by June 10 of a special acquisition company of $ 200 million, Cointelegraph reported on June 10.
The announcement of parataxy occurs in the middle of a wave of business bitcoin adoption. More than 237 public companies now hold Bitcoin on their balance sheets, compared to 124 companies a few weeks earlier, representing approximately 3.96% of the total BTC supply, according to BitcoinTareries.net.
In relation: Fintech Mercurity, listed at the Nasdaq, to raise $ 800 million for Bitcoin Treasury
The gatherings of the action follow the announcements of the treasure
Bridge Biotherapeutics actions have increased by more than 20% on the daily graph after news from acquisition, according to tradingView data. However, the actions of the biotechnological company dropped by 74% for the start of the year and more than 90% compared to its five -year summit.
Founded in 2015 and listed on the automated quotes of Korean merchants in 2019, Bridge Biotherapeutics develops therapies for the treatment of ulcerative colitis, fibrotic diseases and cancer.
Earlier in the day, the company of artificial intelligence solutions based in London, Pri0R1Ty Intelligence Group, announced its intention to adopt Bitcoin as an asset and reserve payment solution without disclosing a direct Bitcoin investment.
After the announcement, the company’s equity price increased by more than 84% on the daily graph, reversing its downward trend of 32%, according to Google financing data.
Not all companies do not benefit. Gamesop’s actions fell by more than 22% after the video game retailer increased its convertible ticket offer to $ 2.25 billion, which some analysts have interpreted as a signal of new investments related to crypto.
https://www.youtube.com/watch?v=EF3WCSS75QY
Review: Arthur Hayes $ 1 million Bitcoin Tip, Altcoins ‘powerful rally’ looms: Hodler’s Digest, May 11-17, 17
